Phosphosignature predicts dasatinib response in non-small cell lung cancer.
Klammer M, Kaminski M, Zedler A, Oppermann F, Blencke S, Marx S, Müller S, Tebbe A, Godl K, Schaab C.
Klammer M, et al. Among authors: tebbe a.
Mol Cell Proteomics. 2012 Sep;11(9):651-68. doi: 10.1074/mcp.M111.016410. Epub 2012 May 21.
Mol Cell Proteomics. 2012.
PMID: 22617229
Free PMC article.